Search

Your search keyword '"Friese, Manuel A"' showing total 509 results

Search Constraints

Start Over You searched for: Author "Friese, Manuel A" Remove constraint Author: "Friese, Manuel A"
509 results on '"Friese, Manuel A"'

Search Results

1. Ferroptosis in health and disease.

5. Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology

6. The NR4A2/VGF pathway fuels inflammation-induced neurodegeneration via promoting neuronal glycolysis

7. Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination

10. Vagus nerve inflammation contributes to dysautonomia in COVID-19

11. 14-3-3 ζ/δ-reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2

12. Mucosal-associated invariant T cells contribute to suppression of inflammatory myeloid cells in immune-mediated kidney disease

14. CXCR5+PD-1++ CD4+ T cells colonize infant intestines early in life and promote B cell maturation

18. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

22. Neuronal vulnerability and multilineage diversity in multiple sclerosis

23. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

26. Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity

27. Immune signature of multiple sclerosis-associated depression

29. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

30. Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19

32. An automated and high-throughput-screening compatible pluripotent stem cell-based test platform for developmental and reproductive toxicity assessment of small molecule compounds

34. Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: sustained improvement in cognition and quality of life

35. 14-3-3 $$\upzeta /\updelta$$-reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2

36. MicroRNA-92a–CPEB3 axis protects neurons against inflammatory neurodegeneration

37. A2A adenosine receptor-driven cAMP signaling in olfactory bulb astrocytes is unaffected in experimental autoimmune encephalomyelitis

39. Identification of the factor XII contact activation site enables sensitive coagulation diagnostics

41. CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis

43. Calcium channel β3 subunit regulates ATP-dependent migration of dendritic cells

45. Male offspring born to mildly ZIKV-infected mice are at risk of developing neurocognitive disorders in adulthood

48. A2A adenosine receptor-driven cAMP signaling in olfactory bulb astrocytes is unaffected in experimental autoimmune encephalomyelitis.

49. Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis.

50. Absence of self-reported neuropsychiatric and somatic symptoms after Omicron variant SARS-CoV-2 breakthrough infections

Catalog

Books, media, physical & digital resources